DMK Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of DMK Pharmaceuticals Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. DMK Pharmaceuticals Corp market cap is $1,000.00.
What is the 52-week high for DMK Pharmaceuticals Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. DMK Pharmaceuticals Corp 52 week high is $0.001 as of October 10, 2025.
What is the 52-week low for DMK Pharmaceuticals Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. DMK Pharmaceuticals Corp 52 week low is $0.00 as of October 10, 2025.
What is DMK Pharmaceuticals Corp stock price today?
DMK Pharmaceuticals Corp stock price today is $0.0001.
What is the 50-day moving average of DMK Pharmaceuticals Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. DMK Pharmaceuticals Corp 50-day moving average is $0.00.